Skip to main content
. 2020 Jun 26;8(6):e17567. doi: 10.2196/17567

Table 1.

Summary of differences between risk classes.

Class Documentation Notified body involved? QMSa Certificates Clinical investigation
I (low risk) Manufacturer must compile the technical documentation and self-declare conformity No Yes No Not mandatory. May be required depending on the outcome of the clinical evaluation
IIa (low-medium risk) Manufacturer must draw up the technical documentation and apply to a European Notified Body Yes Yes, certified Yes (Annex IX certificate, QMS certificate) Not mandatory. May be required depending on the outcome of the clinical evaluation
IIb (medium-high risk) Manufacturer must draw up the technical documentation and apply to a European Notified Body Yes Yes, certified Yes (Annex IX certificate, QMS certificate) Not mandatory. May be required depending on the outcome of the clinical evaluation
III (high risk) Manufacturer must draw up the technical documentation and apply to a European Notified Body Yes, expert panel Yes, certified Yes (Annex IX certificate, QMS certificate) Mandatory

aQMS: Quality Management System.